Skip to main content

Table 5 Primary medical condition reported by 61,379 patients seeking medical cannabis certification, by gender

From: Medical cannabis use in the United States: a retrospective database study

Primary Condition

Patients, n (%)

Male, n (%)

Female, n (%)

n = 61,379

n = 33,651

n = 23,209

Unspecified Chronic Pain

23,817 (38.8%)

14,164 (42.1%)

8710 (37.5%)

Anxiety

8280 (13.5%)

3949 (11.7%)

3224 (13.9%)

Post Traumatic Stress Disorder

5143 (8.4%)

2874 (8.5%)

1982 (8.5%)

Back & Neck Problems

3969 (6.5%)

2506 (7.4%)

1125 (4.8%)

Arthritis

2395 (3.9%)

1149 (3.4%)

1048 (4.5%)

Insomnia

2096 (3.4%)

1187 (3.5%)

673 (2.9%)

Cancer Related Pain

1641 (2.7%)

782 (2.3%)

722 (3.1%)

Depression

1249 (2.0%)

575 (1.7%)

470 (2.0%)

Migraines

1245 (2.0%)

499 (1.5%)

656 (2.8%)

Muscle Spasms

1038 (1.7%)

624 (1.9%)

384 (1.7%)

ADD/ADHD

1002 (1.6%)

624 (1.9%)

235 (1.0%)

Chronic Nausea

926 (1.5%)

477 (1.4%)

419 (1.8%)

Fibromyalgia

726 (1.2%)

70 (0.2%)

597 (2.6%)

Headaches

707 (1.2%)

356 (1.1%)

307 (1.3%)

Epilepsy

626 (1.0%)

372 (1.1%)

224 (1.0%)

Other

6519 (10.6%)

3443 (10.2%)

2433 (10.5%)

  1. Table 5 presents a summary of the individuals reporting each primary condition overall and by gender. Patients could only report one primary condition. Any condition representing less than 1.0% was grouped as an “other”. A list of “other” primary conditions is available in Table 8. Percentages are calculated from the sample size for each respective column. ADD attention deficit disorder, ADHD attention deficit hyperactivity disorder